Bracco Diagnostics announced the launch of its PROTOCO2L TOUCH Colon Insufflator that inflates the colon with carbon dioxide in patients who undergo CT colonography (CTC) for the detection of colon cancer.

In June 2016, the U.S. Preventative Services Task Force (USPSTF) classified CTC as a Grade A screening test because of its effectiveness.

"CTC offers clinicians and patients a fast and reliable screening test with an added benefit for patients in that they do not need to undergo sedation. This means that a patient does not need to have someone else drive them to and from their CTC exam, and the patient does not need to take a day away from their work,” said Alberto Spinazzi, MD, senior vice president in the Bracco Group's Global Medical and Regulatory Affairs.

The device is used in CTC exams to obtain optical distension of the colon. The device utilizes automated insufflation of carbon dioxide, which is more rapidly absorbed with less post-procedural discomfort than regular air. With this device, clinicians will have access to the touch screen, digital technology and other features for procedural efficiency that was not available from previous generations of colon insufflators.